Navigation Links
Omnicell Announces Third Quarter 2010 Results
Date:10/27/2010

p>Founded in 1992, Omnicell's medication-use solutions include complete automation systems for the central pharmacy, anesthesia workstations for the operating room, dispensing cabinet systems for nursing units, and safe, secure medication transportation and verification systems to the patient bedside. From a medication's arrival at the receiving dock to its dosing to the patient, Omnicell systems store it, package it, bar code it, order it, issue it, and provide information and controls on its use and reorder.

Omnicell supply product lines provide a healthcare institution with comprehensive supply chain solutions that result in fast, effective control of costs, capture of charges for payer reimbursement, and timely reorder of supplies. Products range from high-security closed-cabinet systems and software to open-shelf and combination solutions in the nursing unit, cath lab and operating room.

For more information, visit www.omnicell.com.

Forward-Looking StatementsTo the extent any statements contained in this release deal with information that is not historical, these statements are necessarily forward-looking. As such, they are subject to the occurrence of many events outside Omnicell's control and are subject to various risk factors that could cause actual results to differ materially from those expressed or implied in any forward-looking statement. The risk factors are described in the Company's Securities and Exchange Commission (SEC) filings and include, without limitation, the unfavorable general economic and market conditions, the tightening in the credit market, the continued growth and acceptance of our products and services and the continued growth of the clinical automation and workflow automation market generally, the potential of increasing competition, the ability of the company to improve sales productivity, to grow product backlog, retain key personnel, cut expenses, manage future changes
'/>"/>

SOURCE Omnicell, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. RICE MEMORIAL HOSPITAL PHARMACY STAFF EXPERIENCES A 55% REDUCTION IN TIME SPENT MANAGING PATIENT-SPECIFIC MEDICATIONS USING OMNICELL SINGLEPOINTE SOLUTION
2. Omnicell Announces Fourth Quarter and Full-Year 2009 Results
3. Omnicell Selected by Nations Third Largest Public Healthcare System for Medication Management Systems
4. Omnicells OmniLinkRx Honored With KLAS Award for Product Leadership
5. Omnicells Automated Medication Dispensing System Honored With 2010 Best in KLAS Award
6. Omnicells OmniCenter Achieves VMware Ready(TM) Healthcare Virtualization Status
7. Omnicell Introduces New Omnicell Packager With WorkflowRx Software for Improved Pharmacy Efficiency
8. Wellmont Health System Selects Omnicell for Best-in-Class Medication Management
9. Deaconess Health System Selects Omnicells Medication Management System for Product Reliability and Improved Patient Care
10. Omnicell Acquires Pandora Data Systems
11. Omnicell to Release Third Quarter 2010 Earnings Results on October 27
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... CVS Caremark Corporation (NYSE: CVS ) announced today ... in connection with its previously announced cash tender offers (the ... and all of its 6.250% Senior Notes due 2027 (the ... amount of its 6.125% Senior Notes due 2039, 5.750% Senior ... the "Maximum Tender Offer Notes" and together with the Any ...
(Date:8/21/2014)... /CNW/ - Bedrocan Cannabis Corp., previously Bedrocan Canada Inc. ... Board of Directors, enhancing executive oversight and strengthening ... leading licensed producer of medicinal cannabis in ... years, experience in producing and supplying government-regulated pharmaceutical-grade ... As previously announced in a ...
(Date:8/21/2014)... , Aug. 21, 2014  SI-BONE, Inc. ( ... that pioneered the use of the iFuse Implant System, ... for fusion of the sacroiliac (SI) joint, announced that ... update to its Lumbar Fusion Medical Policy No. 91590-R4 ... procedure.  The policy states that the fusion procedure, which ...
Breaking Medicine Technology:CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 3CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 4CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 5CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 6Senior Life Sciences Executives Join Bedrocan as Independent Directors 2Senior Life Sciences Executives Join Bedrocan as Independent Directors 3SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 2SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 3
... QPT: TSX Venture Exchange, EDMONTON, May 02, 2007 ... Quest is pleased to provide an,update on the ... cancer. , Prostate cancer is the second leading ... 230,000 new cases and 30,000 deaths,per year. Current ...
... 2007 - Acorda Therapeutics, Inc.(R),(Nasdaq: ACOR) today ... trial,of Fampridine-SR in people with multiple sclerosis ... Andrew Goodman, M.D.,Director of the Multiple Sclerosis ... results on walking ability, leg,strength, spasticity and ...
Cached Medicine Technology:Quest PharmaTech's Prostate Cancer Program Update 2Quest PharmaTech's Prostate Cancer Program Update 3Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 2Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 3Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 4Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 5Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 6Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 7
(Date:8/21/2014)... York (PRWEB) August 21, 2014 According ... Research "Medical Fiber Optics Market-Global Industry Analysis, Size, Share, ... medical fiber optics market was valued at USD 863.1 ... a CAGR of 7.6% from 2013 to 2019, to ... 2019. , The medical fiber optics market is witnessing ...
(Date:8/21/2014)... Maryland (PRWEB) August 21, 2014 ... with guidance from Lockton Companies and builds on ... industry’s only cellular glucometer, combined with Accountable Health’s ... robust data analytic capabilities and adds a custom ... care, including eye exams, provider visits, HbA1c testing ...
(Date:8/21/2014)... Aspen Advisors, a U.S.-based healthcare consulting firm, ... Modern Healthcare’s Best Places to Work in Healthcare ... healthcare industry for creating workplaces that enable employees to perform ... employee responses to an employee engagement and satisfaction survey. ... has been named a “Best Places to Work in Healthcare”. ...
(Date:8/21/2014)... on in the morning? Do we drive to work or ... to buy lunch? We make hundreds of different decisions every ... it is extremely important for our long-term personal development to ... ADHD often find this difficult, however. They are known to ... but smaller reward instead of making a choice that yields ...
(Date:8/21/2014)... August 21, 2014 Artisan Business Group ... Investment Exploratory Delegation to southern China October 12-19, 2014. ... explore the rapid growing cities of Shenzhen and Guangzhou. ... have the rare opportunity to meet with major Chinese ... a short weeklong time frame. , The trade ...
Breaking Medicine News(10 mins):Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 2Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 3Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 4Health News:Accountable Health Expands Diabetes Management Solutions to Address Gaps in Provider Care 2Health News:Accountable Health Expands Diabetes Management Solutions to Address Gaps in Provider Care 3Health News:Modern Healthcare Names Aspen Advisors Among the Top 100 Employers in the Healthcare Industry for a Fourth Consecutive Year 2Health News:ADHD children make poor decisions due to less differentiated learning processes 2Health News:Artisan Business Group announces 2014 EB-5 Investment Trade Mission to China 2
... 22 Weight Watchers,International, Inc. (NYSE: WTW ) ... a written plan for the purpose of,selling limited amounts ... adopted in accordance with Rule 10b5-1 of the Securities ... to exercise stock,options to diversify his holdings for financial ...
... in hemodialysis patients , , FRIDAY, Feb. 22 (HealthDay News) ... control in people with diabetes gives inaccurate results for ... Hemodialysis, used to treat patients with kidney failure, involves ... machine. , This Wake Forest University Baptist Medical ...
... The following statement,was issued today by William ... Kids:, The Nebraska Legislature has delivered a ... breathe clean air by passing legislation to make,all ... urge Governor Dave Heineman to sign into law ...
... ATLANTA, Feb. 22 Rarely written about, seldom spoken,of, ... the,lives of an astonishing 40% of women and 25% ... and turn what once were ordinary,tasks and activities into ... of 3, found the varicose veins significantly,affected her life ...
... Women of the United States, we,double dare you! ... your risk of cardiovascular disease., Who,s laying down ... the,American Heart Association has challenged women across the country ... to reduce their risks.,RealAge.com, the nation,s leading healthy-lifestyle Web ...
... Mo. More than $1.1 billion a year is spent ... Missouri study reports the state has a rising number of ... with hunger. The MU Interdisciplinary Center for Food Security has ... first Missouri Hunger Atlas details the distribution of hunger in ...
Cached Medicine News:Health News:Weight Watchers COO Adopts 10b5-1 Trading Plan 2Health News:Current Blood Sugar Control Test Results 'Inaccurate' 2Health News:Approval of Nebraska Smoke-Free Legislation is Historic Win for Health 2Health News:Beyond Vanity: New Treatment Brings Relief to Women After Years of Silent Suffering 2Health News:American Heart Month Double Dares Women to Beat Health Foes 2Health News:MU research team releases first Missouri Hunger Atlas 2
... (IFA) test for the detection and semi-quantitation ... Louis Encephalitis virus (SLE), Western Equine Encephalitis ... and California Encephalitis/La Crosse virus (CE). Each ... individual spots of SLE, WEE, EEE, and ...
... Indirect immunofluorescent antibody (IFA) ... and semi-quantitation of human ... Epstein-Barr viral capsid antigen ... ten 12-well slides, FITC ...
... immunofluorescent (ACIF) antibody test ... semi-quantitation of human serum ... antigens of Epstein-Barr virus ... ten 12-well slides, EBNA ...
... DonJoy SpinaLogic is a portable, battery-powered, micro-controlled, ... adjunct electromagnetic treatment to primary lumbar spinal ... This treatment has been shown in ... healing process begin working. Clinical studies have ...
Medicine Products: